Doximity Inc (NYSE: DOCS) on Tuesday, plunged -1.09% from the previous trading day, before settling in for the closing price of $53.28. Within the past 52 weeks, DOCS’s price has moved between $22.96 and $61.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 43.01%. The company achieved an average annual earnings per share of 21.28%. With a float of $123.70 million, this company’s outstanding shares have now reached $128.22 million.
The extent of productivity of a business whose workforce counts for 827 workers is very important to gauge. In terms of profitability, gross margin is 89.94%, operating margin of 38.66%, and the pretax margin is 43.79%.
Doximity Inc (DOCS) Insider and Institutional Ownership
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Doximity Inc is 33.74%, while institutional ownership is 61.57%. The most recent insider transaction that took place on Nov 12 ’24, was worth 5,842,248. In this transaction Chief Financial Officer of this company sold 100,000 shares at a rate of $58.42, taking the stock ownership to the 304,506 shares. Before that another transaction happened on Nov 12 ’24, when Company’s Officer proposed sale 70,000 for $60.00, making the entire transaction worth $4,200,000.
Doximity Inc (DOCS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 21.28% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.34% during the next five years compared to 193.38% growth over the previous five years of trading.
Doximity Inc (NYSE: DOCS) Trading Performance Indicators
Doximity Inc (DOCS) is currently performing well based on its current performance indicators. A quick ratio of 7.21 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.04. Likewise, its price to free cash flow for the trailing twelve months is 45.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.87, a number that is poised to hit 0.34 in the next quarter and is forecasted to reach 1.26 in one year’s time.
Technical Analysis of Doximity Inc (DOCS)
The latest stats from [Doximity Inc, DOCS] show that its last 5-days average volume of 1.4 million was inferior to 1.75 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 30.57%. Additionally, its Average True Range was 2.13.
During the past 100 days, Doximity Inc’s (DOCS) raw stochastic average was set at 75.37%, which indicates a significant increase from 30.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.36% in the past 14 days, which was lower than the 78.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $48.24, while its 200-day Moving Average is $34.62. Now, the first resistance to watch is $53.46. This is followed by the second major resistance level at $54.21. The third major resistance level sits at $54.69. If the price goes on to break the first support level at $52.22, it is likely to go to the next support level at $51.73. The third support level lies at $50.98 if the price breaches the second support level.
Doximity Inc (NYSE: DOCS) Key Stats
Market capitalization of the company is 9.84 billion based on 186,692K outstanding shares. Right now, sales total 475,420 K and income totals 147,580 K. The company made 136,830 K in profit during its latest quarter, and 44,150 K in sales during its previous quarter.
